D20 - Development of a robust disease specific functional measure suitable for trials in ambulant and non-ambulant individuals with dysferlinopathy

Autor: James, M., Mayhew, A., Eagle, M., Moore, U., Muni Lofra, R., Hilsden, H., Bettinson, K., Harris, E., Straub, V., Bushby, K.
Zdroj: In Neuromuscular Disorders March 2017 27 Supplement 1:S11-S11
Databáze: ScienceDirect